Drug Trial Radar · NCT04086745
A Study of Baricitinib in Participants With Rheumatoid Arthritis
Last checked: Nov 20, 2026Latest source record: Jul 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,050
Actual
Start
Feb 14, 2020
Primary completion
May 19, 2025
Study completion May 19, 2025
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- Collaborators
- Incyte Corporation
- First posted
- Sep 12, 2019
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This post-marketing study is designed to compare the safety of baricitinib versus tumor necrosis factor (TNF) inhibitors with respect to venous thromboembolic events (VTEs) when given to participants with rheumatoid arthritis (RA).
Conditions
- Rheumatoid Arthritis
Interventions
BaricitinibDrug
Administered orally.
TNF InhibitorDrug
Administered subcutaneously.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pooled JAJA and JAJD: Time From First Dose of Study Treatment to First Event of Venous Thromboembolism (VTE) [Combined Baricitinib Dose Versus TNF Inhibitor]Time frame: From the first dose of study treatment up to 30 days after the last dose or the last study visit, whichever occurs first (approximately up to 6.1 years for JAJA and 5.3 years for JAJD participants)
Locations
119 sites in 1 country. Site status is shown where the registry gives one.
Arizona Research Clinic PLLC
Chandler, Arizona
Arizona Arthritis & Rheumatology Associates, P. C.
Mesa, Arizona
Arizona Arthritis & Rheumatology Research
Paradise Valley, Arizona
Sun Valley Arthritis Center, LTD
Peoria, Arizona
Arizona Arthritis & Rheumatology Associates
Phoenix, Arizona
Arthritis and Rheumatism Associates
Jonesboro, Arkansas
Providence St. Joseph's Medical Center
Burbank, California
Hope Clinical Research, Inc.
Canoga Park, California
Medvin Clinical Research - Covina
Covina, California
TriWest Research Associates LLC
El Cajon, California
Newport Huntington Med Grp
Huntington Beach, California
BioSolutions Clinical Research Center
La Mesa, California
Valerius Medical Group and Research Center of Greater Long Beach
Los Alamitos, California
R. Srinivasan, M.D., Inc. dba Monterey Park Medical Center
Monterey Park, California
ACRC Studies
Poway, California
Desert Medical Advances
Rancho Mirage, California
Purushotham & Akther Kotha MD Inc
San Diego, California
East Bay Rheumatology Medical Group, Inc
San Leandro, California
Providence Medical Foundation
Santa Rosa, California
Dan La, MD Inc
Tujunga, California
Office: Dr Robin K Dore
Tustin, California
Inland Rheumatology & Osteoporosis Medical Group
Upland, California
Nazanin Firooz, MD Inc.
West Hills, California
Medvin Clinical Research - Whittier
Whittier, California
Danbury Clinical Research, LLC
Danbury, Connecticut
Delaware Arthritis
Lewes, Delaware
Omega Research Debary, LLC
DeBary, Florida
Cria Center for Rheumatology
Fort Lauderdale, Florida
SIMED Health
Gainesville, Florida
GNP Research at Mark Jaffe, MD
Hollywood, Florida
Rheumatology Center Of Palm Beach, Pllc
Lake Worth, Florida
Arthritis and Rheumatology Center of South Florida
Margate, Florida
Miami Clinical Reserach
Miami, Florida
Felicidad Medical Research
Miami, Florida
Rheumatology Associates of Central Florida
Orlando, Florida
Heuer MD Research
Orlando, Florida
UCF Health Lake Nona Orlando
Orlando, Florida
IRIS Research and Development, LLC
Plantation, Florida
BayCare Health System Inc
St. Petersburg, Florida
West Broward Rheumatology Associates
Tamarac, Florida
Showing 40 of 119 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.